Douglas K. Bishop to CD40 Ligand
This is a "connection" page, showing publications Douglas K. Bishop has written about CD40 Ligand.
Connection Strength
1.163
-
Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade. Clin Dev Immunol. 2013; 2013:986859.
Score: 0.434
-
OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade. J Immunol. 2009 Jan 01; 182(1):379-90.
Score: 0.322
-
The immunobiology of inductive anti-CD40L therapy in transplantation: allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant. 2002 Apr; 2(4):323-32.
Score: 0.202
-
Anti-CD40L monoclonal antibody treatment induces long-term, tissue-specific, immunologic hyporesponsiveness to peripheral nerve allografts. J Reconstr Microsurg. 2008 Apr; 24(3):189-95.
Score: 0.077
-
Requirement for donor and recipient CD40 expression in cardiac allograft rejection: induction of Th1 responses and influence of donor-derived dendritic cells. J Immunol. 2004 Jun 01; 172(11):6626-33.
Score: 0.059
-
IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol. 2003 Jan 15; 170(2):853-60.
Score: 0.053
-
Short-term anti-CD40 ligand costimulatory blockade induces tolerance to peripheral nerve allografts, resulting in improved skeletal muscle function. Plast Reconstr Surg. 2006 Jun; 117(7):2250-8.
Score: 0.017